LEENO Industrial filed its Q1 2026 quarterly report covering January 1 to March 31, 2026. Total revenue mix shows IC Test Sockets contributing 64.10% of sales (KRW 63.9 billion, with KRW 59.6 billion from exports and KRW 4.3 billion domestic), while LEENO PINs accounted for 24.65% (KRW 24.6 billion, KRW 18.8 billion exports and KRW 5.8 billion domestic). The company continues to leverage its 40+ years of expertise in semiconductor test consumables and is expanding into medical device components for ultrasound diagnostic equipment. Standard items like company overview, history, capital changes, and share details are omitted per quarterly reporting rules and will appear in semi-annual/annual reports. Strong export-driven revenue concentration in semiconductor test sockets indicates continued tailwind from global memory and non-memory chip testing demand.
Full Translation
Quarterly Report
6.5
LEENO Industrial Co., Ltd.
1
Y
180111-0220664
Quarterly Report
(31st Fiscal Year)
Fiscal Year: From January 1, 2026 to March 31, 2026
To: Financial Services Commission
To: Korea Exchange
Date: May 14, 2026
Filing Entity Type: Listed Stock Corporation
Exemption Reason: None applicable
Company Name: LEENO Industrial Co., Ltd.
CEO: Lee Chae-yoon
Head Office: 10, Mieumsandan-ro 105beon-gil, Gangseo-gu, Busan
(Phone) 051-831-3232
(Website) https://leeno.com/kr
Responsible Officer: (Title) Managing Director (Name) Choi Yong-gi
(Phone) 051-831-3232
Table of Contents
[Confirmation by CEO, etc.] — 1
I. Company Overview — 2
1. Company Overview — 2
2. Company History — 3
3. Changes in Capital — 4
4. Total Number of Shares, etc. — 5
5. Articles of Incorporation Matters — 6
II. Business Content — 7
1. Business Overview — 7
2. Major Products and Services — 9
3. Raw Materials and Production Facilities — 10
4. Sales and Order Status — 13
5. Risk Management and Derivative Transactions — 16
6. Major Contracts and R&D Activities — 20
7. Other Reference Items — 35
III. Financial Matters — 42
1. Summary Financial Information — 42
2. Consolidated Financial Statements — 44
3. Notes to Consolidated Financial Statements — 45
4. Financial Statements — 46
5. Notes to Financial Statements — 52
6. Dividend Matters — 121
7. Capital Raising via Securities Issuance — 124
8. Other Financial Matters — 127
IV. Directors' Management Diagnosis and Analysis Opinion — 135
V. Auditor's Audit Opinion, etc. — 137
1. External Audit Matters — 137
2. Internal Control Matters — 139
VI. Board of Directors and Corporate Bodies — 140
1. Board of Directors — 140
2. Audit System — 141
3. Shareholders' Meetings, etc. — 142
VII. Shareholders — 146
VIII. Officers and Employees — 147
1. Status of Officers and Employees — 147
2. Officer Compensation — 149
IX. Affiliated Companies — 150
X. Transactions with Major Shareholders — 151
XI. Other Matters for Investor Protection — 152
1. Progress and Changes in Disclosure Content — 152
2. Contingent Liabilities, etc. — 153
3. Sanctions and Related Matters — 154
4. Major Subsequent Events After Reporting Date — 155
XII. Detailed Tables — 156
1. Status of Consolidated Subsidiaries (Detailed) — 156
2. Status of Affiliated Companies (Detailed) — 157
3. Status of Investments in Other Entities (Detailed) — 158
[Expert Confirmation] — 159
1. Expert Confirmation — 159
2. Relationship with Expert — 159
[Confirmation by CEO, etc.]
Confirmation.jpg
Confirmation
I. Company Overview
1. Company Overview
Company overview is not included in the quarterly report per disclosure form preparation standards. (Will be included in semi-annual/annual report.)
2. Company History
Company history is not included in the quarterly report per disclosure form preparation standards. (Will be included in semi-annual/annual report.)
3. Changes in Capital
Changes in capital are not included in the quarterly report per disclosure form preparation standards. (Will be included in semi-annual/annual report.)
4. Total Number of Shares, etc.
Not included in the quarterly report per disclosure form preparation standards. (Will be included in semi-annual/annual report.)
5. Articles of Incorporation Matters
Not included in the quarterly report per disclosure form preparation standards. (Will be included in semi-annual/annual report.)
II. Business Content
1. Business Overview
The Company develops, manufactures, and sells under its own brand inspection PROBES (SPRING CONTACT PROBE: LEENO PIN) and semiconductor test sockets (IC TEST SOCKET), which were previously entirely dependent on imports, and also manufactures and sells medical device components applied in products such as ultrasound diagnostic equipment.
[LEENO PIN & IC TEST SOCKET Segment]
Based on over 40 years of experience and accumulated know-how, the Company possesses a production system capable of responding to multi-product and short-delivery demands. Additionally, the IC TEST SOCKET incorporating the LEENO PIN — first developed domestically by the Company — offers the strength of stably testing electrical/electronic components and semiconductor chips. The Company has established an in-house production system covering all processes, securing advantages in stable quality maintenance, cost competitiveness, and short lead times. Using its accumulated technological capabilities and know-how, the Company continuously strives to supply leading products that meet customer demands even in rapidly changing market environments.
In overseas markets, the Company responds through various distribution methods including indirect sales via agents and direct sales to overseas local buyers. In the domestic market, it has established a strategic technical sales system, enabling rapid response from early product development through mass production.
Based on Q1 2026 revenue, IC TEST SOCKETS — consumable parts for semiconductor (memory and non-memory) test packaging equipment — accounted for 64.10% of total revenue (KRW 63.9 billion: overseas exports KRW 59.6 billion, domestic KRW 4.3 billion). LEENO PINs — consumable parts that check electrical defects in semiconductors or printed circuit boards — accounted for 24.65% of total revenue (KRW 24.6 billion: overseas exports KRW 18.8 billion, domestic KRW 5.8 billion). Other merchandise accounted for 0.03% (KRW 30 million).
[Medical Device Segment]
The Company possesses a flexible production system capable of responding to multi-product and short-delivery demands. Based on the precision manufacturing process know-how accumulated through manufacturing LEENO PINs and IC TEST SOCKETS, the Company has secured differentiated competitiveness in the ultrasound diagnostic equipment market.
[Translation truncated]
Past performance does not guarantee future results. Small sample sizes may not be representative. For informational purposes only.